机译:基于生理学的药代动力学模型,评估影响美容额外释放产品的生物等效性的配方因素
Center for Pharmacometrics and Systems PharmacologyUniversity of FloridaOrlando FL USA;
Center for Pharmacometrics and Systems PharmacologyUniversity of FloridaOrlando FL USA;
Food and Drug AdministrationOffice of Generic DrugsSilver Spring MD USA;
Food and Drug AdministrationOffice of Generic DrugsSilver Spring MD USA;
Food and Drug AdministrationOffice of Generic DrugsSilver Spring MD USA;
Center for Pharmacometrics and Systems PharmacologyUniversity of FloridaOrlando FL USA;
Center for Pharmacometrics and Systems PharmacologyUniversity of FloridaOrlando FL USA;
Center for Pharmacometrics and Systems PharmacologyUniversity of FloridaOrlando FL USA;
Physiologically based pharmacokinetic modeling; Absorption modeling; Generic drug products; Bioinequivalence; Bioequivalence; Extended Release; Metoprolol;
机译:基于生理学的药代动力学模型,评估影响美容额外释放产品的生物等效性的配方因素
机译:使用基于生理的药代动力学模型评估狗拉西地平口服制剂的生物等效性的虚拟人群药代动力学 sup>
机译:使用基于生理的药代动力学模型评估狗口服拉西地平制剂的生物等效性的虚拟群体药代动力学
机译:普拉克索缓释和速释制剂的药代动力学评估
机译:硝苯地平新型喷雾包衣的软弹性明胶胶囊缓释制剂的开发,维拉帕米盐酸盐控释制剂的生物利用度和生物等效性,在猛禽中单次口服剂量后特比萘芬的药代动力学。
机译:使用基于生理的药代动力学模型评估狗口服拉地平制剂的生物等效性的虚拟人群药代动力学
机译:使用基于生理的药代动力学模型评估狗口服拉地平制剂的生物等效性的虚拟群体药代动力学
机译:人体内二氯乙酸动力学的定量评价 - 基于生理学的药代动力学模型研究